Drug
Tivozanib Paclitaxel
Tivozanib Paclitaxel: highest development phase Phase 1, developed by Aveo Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Aveo Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| tivozanib (AV-951) + paclitaxel NCT00717340 | Phase 1 | Metastatic Breast Cancer |
| Tivozanib + paclitaxel NCT01369433 | Not Applicable | Solid Tumors |
Latest
No recent events.
Follow Tivozanib Paclitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.